Integra LifeSciences Holdings Corporation (IART) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and welcome to Integra Life Sciences first quarter 2026 financial results. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question, please press star 11 on your touchstone telephone. Also note this call is being recorded. I would like to turn the call over to Chris Ward, Senior Director of Investor Relations. Please go ahead. Good morning, and thank you for joining the Integral Life Sciences first quarter 2026 earnings conference call. Joining me on the call are Stuart Essig, Chairman, President, and Chief Executive Officer, and Leah Knight, Chief Financial Officer. This morning, we issued two press releases, the first announcing the CEO transition and other organizational changes, and the second announcing our first quarter 2026 financial results. The releases and earnings presentation that we will reference during the call available at integralife.com under investors events and presentations and a file name first quarter 2026 earnings call presentation before we begin I want to remind you that many statements made during this call may be considered forward-looking factors that could cause actual results to differ materially are discussed in the company's exchange act reports filed with the SEC also in our prepared remarks we will reference reported and organic revenue growth Organic revenue growth excludes the effects of foreign currency, acquisitions, and investitures. Unless otherwise stated, all disaggregated and franchise-level revenue growth rates are based on organic performance. Lastly, our comments today will include certain non-GAAP financial measures. Reconciliations of non-GAAP financial measures are included in today's press release, which is an exh...